Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 16-Oct-24 4:23 PM View:  | Carruthers R Michael Chief Financial Officer | Edgewise Therapeutics, Inc. (EWTX) | 11-Oct-24 | Option Exercise | 70,000 | $0.71 | $49,700.00 | 1014% 6.9K to 76.9K | |
| 24-Sep-24 8:25 PM View: | Moore John R General Counsel | Edgewise Therapeutics, Inc. (EWTX) | 23-Sep-24 | Option Sale | 20,922 | $27.63 | $578,064.00 | (87%) 24.17K to 3.25K | |
| 24-Sep-24 8:25 PM View: | Moore John R General Counsel | Edgewise Therapeutics, Inc. (EWTX) | 23-Sep-24 | Option Exercise | 20,922 | $0.71 | $14,854.60 | 643% 3.25K to 24.17K | |
| 24-Sep-24 8:22 PM View: | Carruthers R Michael Chief Financial Officer | Edgewise Therapeutics, Inc. (EWTX) | 20-Sep-24 | Option Exercise | 96,068 | $1.93 | $185,411.00 | 267% 35.93K to 132.0K | |
| 24-Sep-24 8:25 PM View: | Moore John R General Counsel | Edgewise Therapeutics, Inc. (EWTX) | 20-Sep-24 | Option Exercise | 50,000 | $0.71 | $35,500.00 | 1538% 3.25K to 53.25K | |
| 24-Sep-24 8:24 PM View: | Derakhshan Behrad Chief Business Officer | Edgewise Therapeutics, Inc. (EWTX) | 20-Sep-24 | Option Sale | 42,068 | $29.03 | $1,221,130.00 | (74%) 57.19K to 15.12K | |
| 24-Sep-24 8:25 PM View: | Russell Alan J Chief Scientific Officer Director | Edgewise Therapeutics, Inc. (EWTX) | 20-Sep-24 | Option Sale | 75,000 | $28.27 | $2,120,100.00 | (86%) 87.72K to 12.72K | |
| 24-Sep-24 8:22 PM View: | Carruthers R Michael Chief Financial Officer | Edgewise Therapeutics, Inc. (EWTX) | 20-Sep-24 | Option Sale | 96,068 | $28.57 | $2,744,740.00 | (73%) 132.0K to 35.93K | |
| 24-Sep-24 8:24 PM View: | Donovan Joanne M. CMO | Edgewise Therapeutics, Inc. (EWTX) | 20-Sep-24 | Private Sale | 7,162 | $28.29 | $202,603.00 | (33%) 21.7K to 14.54K | |
| 24-Sep-24 8:22 PM View: | Carruthers R Michael Chief Financial Officer | Edgewise Therapeutics, Inc. (EWTX) | 20-Sep-24 | Sale | 29,024 | $28.57 | $829,239.00 | (81%) 35.93K to 6.9K | |
| 24-Sep-24 8:25 PM View: | Moore John R General Counsel | Edgewise Therapeutics, Inc. (EWTX) | 20-Sep-24 | Option Sale | 50,000 | $28.37 | $1,418,510.00 | (94%) 53.25K to 3.25K | |
| 24-Sep-24 8:24 PM View: | Derakhshan Behrad Chief Business Officer | Edgewise Therapeutics, Inc. (EWTX) | 20-Sep-24 | Option Exercise | 42,068 | $1.93 | $81,191.20 | 278% 15.12K to 57.19K | |
| 24-Sep-24 8:25 PM View: | Russell Alan J Chief Scientific Officer Director | Edgewise Therapeutics, Inc. (EWTX) | 20-Sep-24 | Option Exercise | 75,000 | $0.18 | $13,500.00 | 590% 12.72K to 87.72K | |
| 03-May-24 6:27 PM View: | Donovan Joanne M. CMO | Edgewise Therapeutics, Inc. (EWTX) | 02-May-24 | Option Sale | 3,682 | $18.91 | $69,626.60 | (16%) 23.58K to 19.9K | |
| 03-May-24 6:29 PM View: | Derakhshan Behrad Chief Business Officer | Edgewise Therapeutics, Inc. (EWTX) | 02-May-24 | Option Sale | 1,718 | $18.91 | $32,487.40 | (11%) 15.14K to 13.42K | |
| 03-May-24 6:26 PM View: | Koch Kevin President and CEO Director | Edgewise Therapeutics, Inc. (EWTX) | 02-May-24 | Option Sale | 3,152 | $18.91 | $59,604.30 | (< 1%) 356.41K to 353.26K | |
| 03-May-24 6:28 PM View: | Russell Alan J Chief Scientific Officer Director | Edgewise Therapeutics, Inc. (EWTX) | 02-May-24 | Option Sale | 1,576 | $18.91 | $29,802.20 | (18%) 8.81K to 7.24K | |
| 03-May-24 6:30 PM View: | Carruthers R Michael Chief Financial Officer | Edgewise Therapeutics, Inc. (EWTX) | 02-May-24 | Option Sale | 2,157 | $18.91 | $40,788.90 | (6%) 37.39K to 35.23K | |
| 03-May-24 6:31 PM View: | Moore John R General Counsel | Edgewise Therapeutics, Inc. (EWTX) | 02-May-24 | Option Sale | 1,956 | $18.91 | $36,988.00 | (38%) 5.21K to 3.25K | |
| 03-May-24 6:27 PM View: | Donovan Joanne M. CMO | Edgewise Therapeutics, Inc. (EWTX) | 01-May-24 | Option Exercise | 10,417 | -- | -- | 79% 13.16K to 23.58K | |
| 03-May-24 6:30 PM View: | Carruthers R Michael Chief Financial Officer | Edgewise Therapeutics, Inc. (EWTX) | 01-May-24 | Option Exercise | 5,208 | -- | -- | 16% 32.18K to 37.39K | |
| 03-May-24 6:31 PM View: | Moore John R General Counsel | Edgewise Therapeutics, Inc. (EWTX) | 01-May-24 | Option Exercise | 5,208 | -- | -- | 100% 0 to 5.21K | |
| 03-May-24 6:29 PM View: | Derakhshan Behrad Chief Business Officer | Edgewise Therapeutics, Inc. (EWTX) | 01-May-24 | Option Exercise | 5,208 | -- | -- | 52% 9.93K to 15.14K | |
| 03-May-24 6:26 PM View: | Koch Kevin President and CEO Director | Edgewise Therapeutics, Inc. (EWTX) | 01-May-24 | Option Exercise | 10,417 | -- | -- | 3% 346.0K to 356.41K | |
| 03-May-24 6:28 PM View: | Russell Alan J Chief Scientific Officer Director | Edgewise Therapeutics, Inc. (EWTX) | 01-May-24 | Option Exercise | 5,208 | -- | -- | 144% 3.61K to 8.81K | |
| 09-Feb-24 5:42 PM View: | Derakhshan Behrad Chief Business Officer | Edgewise Therapeutics, Inc. (EWTX) | 09-Feb-24 | Option Sale | 4,800 | $20.04 | $96,209.30 | (41%) 11.82K to 7.02K | |
| 09-Feb-24 5:43 PM View: | Moore John R General Counsel | Edgewise Therapeutics, Inc. (EWTX) | 09-Feb-24 | Option Sale | 8,029 | $20.01 | $160,657.00 | (100%) 8.03K to 0 | |
| 09-Feb-24 5:43 PM View: | Moore John R General Counsel | Edgewise Therapeutics, Inc. (EWTX) | 09-Feb-24 | Option Exercise | 8,029 | $1.93 | $15,496.00 | 100% 0 to 8.03K | |
| 09-Feb-24 5:42 PM View: | Derakhshan Behrad Chief Business Officer | Edgewise Therapeutics, Inc. (EWTX) | 09-Feb-24 | Option Exercise | 4,800 | $1.93 | $9,264.00 | 68% 7.02K to 11.82K | |
| 09-Feb-24 5:43 PM View: | Moore John R General Counsel | Edgewise Therapeutics, Inc. (EWTX) | 08-Feb-24 | Option Sale | 3,813 | $20.01 | $76,284.80 | (100%) 3.81K to 0 | |
| 09-Feb-24 5:43 PM View: | Moore John R General Counsel | Edgewise Therapeutics, Inc. (EWTX) | 08-Feb-24 | Option Exercise | 3,813 | $1.93 | $7,359.09 | 100% 0 to 3.81K | |
| 09-Feb-24 5:42 PM View: | Derakhshan Behrad Chief Business Officer | Edgewise Therapeutics, Inc. (EWTX) | 08-Feb-24 | Option Exercise | 4,600 | $1.93 | $8,878.00 | 66% 7.02K to 11.62K | |
| 09-Feb-24 5:42 PM View: | Derakhshan Behrad Chief Business Officer | Edgewise Therapeutics, Inc. (EWTX) | 08-Feb-24 | Option Sale | 4,600 | $20.01 | $92,048.80 | (40%) 11.62K to 7.02K | |
| 09-Feb-24 5:43 PM View: | Moore John R General Counsel | Edgewise Therapeutics, Inc. (EWTX) | 07-Feb-24 | Option Exercise | 17,993 | $1.93 | $34,726.50 | 100% 0 to 17.99K | |
| 09-Feb-24 5:42 PM View: | Derakhshan Behrad Chief Business Officer | Edgewise Therapeutics, Inc. (EWTX) | 07-Feb-24 | Option Exercise | 600 | $1.93 | $1,158.00 | 9% 7.02K to 7.62K | |
| 09-Feb-24 5:42 PM View: | Derakhshan Behrad Chief Business Officer | Edgewise Therapeutics, Inc. (EWTX) | 07-Feb-24 | Option Sale | 600 | $20.00 | $12,000.00 | (8%) 7.62K to 7.02K | |
| 09-Feb-24 5:43 PM View: | Moore John R General Counsel | Edgewise Therapeutics, Inc. (EWTX) | 07-Feb-24 | Option Sale | 17,993 | $20.00 | $359,864.00 | (100%) 17.99K to 0 | |
| 25-Jan-24 4:32 PM View: | Thompson Peter A Director 10% Owner | Edgewise Therapeutics, Inc. (EWTX) | 23-Jan-24 | Private Purchase Duplicate | 454,545 | $11.00 | $5,000,000.00 | 3% 14.3M to 14.76M | |
| 25-Jan-24 4:46 PM View: | Carruthers R Michael Chief Financial Officer | Edgewise Therapeutics, Inc. (EWTX) | 23-Jan-24 | Option Sale | 90,000 | $15.78 | $1,419,760.00 | (76%) 119.02K to 29.02K | |
| 25-Jan-24 4:46 PM View: | Carruthers R Michael Chief Financial Officer | Edgewise Therapeutics, Inc. (EWTX) | 23-Jan-24 | Option Exercise | 90,000 | $1.93 | $173,700.00 | 310% 29.02K to 119.02K | |
| 25-Jan-24 4:28 PM View: | Orbimed Advisors LLC Director 10% Owner | Edgewise Therapeutics, Inc. (EWTX) | 23-Jan-24 | Private Purchase | 454,545 | $11.00 | $5,000,000.00 | 3% 14.3M to 14.76M | |
| 28-Dec-23 4:39 PM View: | Moore John R General Counsel | Edgewise Therapeutics, Inc. (EWTX) | 27-Dec-23 | Sale (Planned) | 8,497 | $10.50 | $89,218.50 | (100%) 8.5K to 0 | |
| 28-Dec-23 4:39 PM View: | Fox Jonathan C Director | Edgewise Therapeutics, Inc. (EWTX) | 26-Dec-23 | Private Purchase | 10,857 | $9.30 | $100,958.00 | 100% 0 to 10.86K | |
| 28-Dec-23 4:38 PM View: | Russell Alan J Chief Scientific Officer Director | Edgewise Therapeutics, Inc. (EWTX) | 26-Dec-23 | Sale | 172,585 | $9.33 | $1,610,100.00 | (98%) 176.19K to 3.61K | |
| 26-Jun-23 4:28 PM View: | Carruthers R Michael Chief Financial Officer | Edgewise Therapeutics, Inc. (EWTX) | 22-Jun-23 | Option Exercise | 10,000 | $0.71 | $7,100.00 | 53% 19.02K to 29.02K | |
| 03-May-23 10:00 PM View: | Carruthers R Michael Chief Financial Officer | Edgewise Therapeutics, Inc. (EWTX) | 02-May-23 | Option Sale | 1,336 | $8.90 | $11,896.90 | (8%) 17.46K to 16.13K | |
| 03-May-23 10:00 PM View: | Russell Alan J Chief Scientific Officer Director | Edgewise Therapeutics, Inc. (EWTX) | 02-May-23 | Option Sale | 1,602 | $8.90 | $14,265.60 | (< 1%) 177.79K to 176.19K | |
| 03-May-23 10:00 PM View: | Moore John R General Counsel | Edgewise Therapeutics, Inc. (EWTX) | 02-May-23 | Option Sale | 1,897 | $8.90 | $16,892.60 | (22%) 8.46K to 6.57K | |
| 03-May-23 10:00 PM View: | Donovan Joanne M. CMO | Edgewise Therapeutics, Inc. (EWTX) | 02-May-23 | Option Sale | 3,254 | $8.90 | $28,976.50 | (25%) 13.21K to 9.96K | |
| 03-May-23 10:00 PM View: | Derakhshan Behrad Chief Business Officer | Edgewise Therapeutics, Inc. (EWTX) | 02-May-23 | Option Sale | 1,747 | $8.90 | $15,556.90 | (20%) 8.77K to 7.02K |
